Cresco Labs, a multi-state cannabis operator, has agreed to acquire all of the issued and outstanding shares of Bluma Wellness Inc. in an all-share transaction that values Bluma Wellness at an equity value of $213 million, the two companies said Thursday. Bluma operates a vertically-integrated, licensed medical cannabis company in Florida.
Under the terms of the transaction, shareholders of Bluma will receive 0.0859 of a subordinate voting share of Cresco Labs for each Bluma Share held by them. The exchange ratio implies a price per Bluma share of about $1.12, representing a nearly 29 percent premium based on the closing price of Bluma shares on the CSE as of January 13, 2021.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.